mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |